We have revised our Privacy Policy that is in effect as of May 25, 2018. Please click here to access it.
Search
Contact Us
Careers
External Funding
News and Media
about us
corporate timeline
Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.
leadership
Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
corporate presentation
We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
ESG report
Corporate social responsibility is important to us, and patients remain at the heart of the work we do every day.
our therapy
our pipeline
clinical trials
Our mechanism of action is broadly applicable across a variety of solid tumors.
novocuretrial.com
The science of Tumor Treating Fields extends beyond glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in mesothelioma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
patient-forward
news and media
press releases
press kits
media gallery
featured stories
investor relations
press releases
corporate presentation
events
annual reports
sec filings
stock information
corporate governance
faq
email alerts
NASDAQ: current stock price
179.27
6.23
last update
5/14/2021 16:00pm
careers
our locations
current job listings
Novocure 2020 Virtual Research & Development Day
View the presentations and videos from the 2020 Virtual Research & Development Day.
presentations
Welcome Remarks – Bill Doyle
Applying basic biology to address critical unmet needs – Dr. Moshe Giladi
Applying basic biology to address critical unmet needs – Dr. Carsten Hagemann
Leveraging physics to address critical unmet needs – Dr. Zeev Bomzon
Leveraging physics to address critical unmet needs – Dr. Matthew Ballo
Product innovation to address critical unmet needs – Frank Leonard
Advancing clinical development – Dr. Ely Benaim
Clinical development: combination with chemotherapy – Dr. Hani Babiker
Clinical development: combination with immunotherapy – Dr. David Tran
Clinical development: combination with radiation therapy – Dr. Wenyin Shi
videos
about us
corporate timeline
Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.
leadership
Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
corporate presentation
We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
ESG report
Corporate social responsibility is important to us, and patients remain at the heart of the work we do every day.
our therapy
our pipeline
clinical trials
Our mechanism of action is broadly applicable across a variety of solid tumors.
novocuretrial.com
The science of Tumor Treating Fields extends beyond glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in mesothelioma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
patient-forward
news and media
press releases
press kits
media gallery
featured stories
investor relations
press releases
corporate presentation
events
annual reports
sec filings
stock information
corporate governance
faq
email alerts
careers
our locations
current job listings
